The New Tripos International Releases Topomer CoMFA(R), A Tool That Automates the Creation of Models for Predicting the Biological Activity of Compounds

ST. LOUIS--(BUSINESS WIRE)--Tripos International, a privately-held, leading provider of drug discovery informatics products and services, today announced the release of Tripos Topomer CoMFA, a 3D QSAR tool that automates the creation of models for predicting the level of biological activity or other properties of chemical compounds. This new product allows Topomer CoMFA models to be created in minutes, not days and usually produces results comparable to the established CoMFA methods.